Cost Benefit Analysis in a Government ContextFMI PD Week: November 25th,2014
Elias Hage, CPA, CA, CISA, Advisory Services, Ernst & Young (EY)Henri Besnier, M.Sc. CPA, CMA, Advisory Services, Ernst & Young (EY)
Page 2
Agenda
► What is a cost benefit analysis
► When and how to use a cost benefit analysis in Government
► Cost benefit analysis examples
► Challenges and success factors
► Questions
Page 4
What is a cost benefit analysis (CBA)?
The purpose of a CBA is to perform an analysis where expected costs and benefits resulting from an opportunity are analyzed for selected scenarios (including status quo).
► The CBA helps to understand and compare the initial and on-going expenditures to the expected financial and non-financial benefits.
► Generally, the first step of a CBA involves an investigation and assessment of the opportunity.
► In examining the preferred option, it is also important to consider alternatives, including the base case (or ‘do nothing’ alternative) for comparative purposes.
Page 5
Components of a CBA
A CBA should contain for a given time period:
► Expected costs► Expected benefits
Page 6
Expected costs
Expected costs should include all internal and external costs over the selected time period. This would include both direct project and ongoing (business as usual) costs.
Examples of types of costs include:► Capital expenditure (e.g. Purchase of a building)
► Operating and maintenance costs (e.g. Fuel)
► Labor costs (e.g. Salaries and benefits)
► Start-up or transition costs (e.g. Disruption to business due to conversion to a new business process)
► Environmental costs (e.g. Remediation of soil at the end of a project )
Project delivery costs may be straightforward to identify; however, indirect costs will require further investigation. Always consider what activities are impacted by the delivery
of the program/project and the resources consumed in the operational cycle.
Page 7
Expected benefits
Expected benefits should be measurable and can be classified as:► Financial► Non-financial – quantitative (e.g. output, efficiency)► Non-financial – qualitative (e.g. customer satisfaction, compliance)
Examples of types of benefits include:► Revenues (e.g. Incremental sales)
► Cost saving (e.g. Reduction of wastes,)
► Productivity improvement (e.g. Process more requests)
► Access to better information (e.g. Citizens can see their electric consumption over internet)
Page 8
Varying complexity of CBA
CBAs can significantly vary in level of complexity. There are several factors which can impact the time and effort required to produce a functional CBA, such as:► Identifying all relevant expected costs or benefits► Availability of data and information to measure expected costs or benefits► Constructing fair alternatives
Com
plex
ity: B
enef
its
Complexity: Costs
High
HighLow
LowLegend
Project / program
C
D
B
F
G
HE
A
Non-complex
Complex
Cost/benefit complexity matrix
It is important to clearly state any assumptions made in determining costs or quantifying and delivering benefits.
Consider the complexity of project E versus project H:► An example of Project E may be the implementation of an
automated envelope stuffer – a low complexity measure of costs and benefits► Expected costs: Cost of purchasing, implementing and maintaining the
hardware► Expected benefits: Avoided cost of staff required to manually stuff the
envelopes
► An example of Project G, on the other hand, may be the replacement of a governmental program – high complexity measure of both costs and benefits► Expected costs: Direct costs may be simple to measure (the cost of
transition); however, indirect costs such as the impact on other programs can be difficult to measure.
► Expected benefits: Security and safety of citizens, but how would this benefit be measured? What factors would be used? What assumptions would be made?
Page 10
DepartmentSubmissionFiscal Framework Treasury Board
Secretariat (TBS)
Treasury Board Cabinet Committee
(TBCC)Start
Annual Budget
(Incremental Funding)
Implementation& Follow-up
Approved?
Yes
No
End
Existing Funding
(reallocation)
New regulation submission process
CBA
A CBA is required for all regulation submissions. Prior to submission to the Treasury Board Secretariat, guidance and validation may be performed with the Treasury Board Centre of Regulatory Expertise
Page 11
Business cases for programs / projects
CBAs are used as part of business cases at the Federal, Provincial and Municipal level, and may not always require review or approval by the Treasury Board Secretariat.
The purpose of a CBA as part of the Government of Canada business case process includes:► Linking investments with program results and strategic outcomes► Effectively communicating the costs and benefits of implementing a
project or program, including relevant assumptions used for measurement
Page 12
Treasury Board CBA process
Identify baseline
Set objectives
Develop alternatives
Cost benefit analysis process
Prepare CBA
Prepare accounting statement
Treasury Board submission
Page 13
Benefits
Market ($)
Willingness to Pay (WTP)
Willingness to Accept (WTA)
Assumptions ($)Revealed Preference
(Observation)
Stated Preference(Survey)
Benefit Transfer(Existing Study)
Other (VSL, QALY, reduced material damages, ecological
benefits)
Page 14
Costs
Private sector(Opportunity costs)
Compliance costs(capital, operating, maintenance,
admin, cost of substitutes)
Transitional Costs
Government
Administrative (Capital, Operating Costs)
Monitoring
Enforcing
Page 15
Summary of Treasury Board CBA
Costs, Benefits & Distribution Base Year … Final Year Total Annual Average
A. QUANTIFIED IMPACTS IN $
Benefits Stakeholders
Costs Stakeholders
Net Benefits
B. QUANTIFIED IMPACTS IN NON-$ – RISK ASSESSMENT, e.g. mortality, morbidity
Positive Impacts Stakeholders
Negative Impacts Stakeholders
C. QUALITATIVE IMPACTS
Short List of Qualitative Impacts (Positive and Negative) by Stakeholders
Treasury Board Secretariat: Regulatory Bootcamp Module 5 - CBA
Illustrated below is a one-table summary of the Treasury Board CBA accounting statement
Page 18
Example: Regulations amending the Food and Drug Regulations
These Regulations will provide a net benefit to Canadians, with a net present value (NPV) of about $33.4 million over 10 years. The quantified benefits relate primarily to cost savings to industry due to removal of poor-quality drug products at the active ingredient (AI) stage instead of recalls at the dosage-form stage. The qualitative benefits relate primarily to better protection for Canadians from poor-quality drug products.
►Option 1: Status Quo►No financial impact►Continued health risks to Canadians
►Option 2: More active and ongoing promotion of the voluntary implementation of GMP for AI►Non-regulatory option►Unlikely to have a material benefit / impact on the existing health risks
►Option 3: Regulatory amendment►Benefits to consumers, government and industry►Costs to government and industry
Costs
Cost-benefit statement
Source: Food and Drug Regulations Regulations SOR - 2013-74 (26-04-2014)
Page 19
Example: Regulations amending the Food and Drug Regulations (continued)
Source: Food and Drug Regulations Regulations SOR - 2013-74 (26-04-2014)
The table shows the cost-benefit analysisA. Quantified impacts ($)
Base Year Final Year Total (PV) Annual Average
Benefits
Industry — “Foreign” inspection fees savings for Canadian manufacturers selling abroad.
$0.7M $1.6M $8.9M $1.3M
Industry — Cost savings due to removal of poor quality drug products at API stage instead of dosage-form stage.
$2.4M $5.6M $34.4M $4.9M
Total benefits $3.1M $7.2M $43.3M $6.2M
Costs
Industry — Training and administration costs for API fabricators, packagers/labellers, testers, importers, distributors and wholesalers.
$1.0M <$0.1M $1.4M <$0.2M
Health Canada —Administration of new requirements.
$0.1M $1.7M $8.5M $1.2M
Total costs $1.1M $1.8M $9.9MNet present value (NPV)
$33.4M
Page 20
Example: Regulations amending the Food and Drug Regulations (continued)
Source: Food and Drug Regulations Regulations SOR - 2013-74 (26-04-2014)
The table shows the cost-benefit analysis (continued)B. Positive qualitative impacts• Potential reduction in the number of recall incidents due to API quality issues.
• Reduced impact of recalls should they occur by helping to narrow down the scope of the recall, through problem identification and record-keeping requirements that allows the isolation of problem lots.
• Consumers and patients, as well as Canada’s international regulatory counterparts, are assured explicitly that API in dosage-form drugs sold in Canada are meeting the international safeguard standard (GMP).
• As the number of jurisdictions requiring API to meet the international standard continues to expand, the implementation of the Regulations will protect Canada against the increased risk of becoming a destination to divert non-GMP-compliant products to, which in turn could translate into health costs to Canadians, and sales and economic costs to business.
• The Regulations will allow Health Canada to establish regulatory equivalence with its international counterparts, enabling Health Canada to reciprocate in international regulatory work-sharing to ensure the safety of the global AI supply.
• Establishing regulatory equivalence will also result in the reduction of duplicative oversight by various regulators internationally, and the reduction of Canadian manufacturers’ worldwide compliance costs, consistent with the Government of Canada’s Red Tape Reduction Initiative.
Other considerations in the CBA:►One-for-one rule►Small business lens
Page 21
Non-regulatory example: Shared services implementation
A large government department is thinking of adopting a shared services model within finance and procurement to reduce FTE costs and potentially improve output. Initiatives being considered include:► Aligning and streamlining processes► Consolidating or interfacing existing technologies (e.g. ERP, budgeting system, collections tools)► Master data cleansing and migration into a ‘single source of truth’► Revisiting the operating model to support centralized transaction processing and streamlined processes
Situation (hypothetical example)
Costs► Capital costs (technology & equipment)► Migration costs (temporary staff augmentation)► Professional services► Training and other costsBenefits► Cost savings due to FTE reduction
Direct costs and benefitsAre there other costs and benefits that may not be apparent, but should be considered when performing a CBA? How are they measured?Costs► Loss of corporate knowledge due to voluntary
departures and/or FTE reductionsBenefits► Improved decision making due to better quality of
budgeting information► Bulk discounts on procurement due to better data► Revenue realization due to ‘single source of truth’
for collections and billing
Indirect costs and benefits
Benefits in one area may result in costs or benefits elsewhere in the delivery chain – it is important to understand all material impacts
along the chain
Page 23
Current CBA challenges in Government
► Choosing the right instrument and design
► Balancing time constraints and accuracy/quality
► Expertise and capacity building within departments
► Lack of standard costs
Page 24
Ten golden rules
1. Start early and continue collecting information throughout the development of the CBA
2. Map out the data collection process before creating models3. The CBA does not have to be “perfect” – 80% science, 20% art4. Identify and define the assumptions being used5. Disclose risks and the cost of managing them6. Compare against a baseline scenario7. Evaluate more than one alternative 8. Objectives should be precise and measurable9. Understand the audience of the CBA10. The CBA should not be impacted by political priorities; it should
provide the most accurate evidence for decision making
Page 25
Resources
► Canadian Cost-Benefit Analysis Guide: Regulatory Proposals► http://www.tbs-sct.gc.ca/rtrap-parfa/analys/analystb-eng.asp
► Business Case Guide► http://www.tbs-sct.gc.ca/emf-cag/business-rentabilisation/bcg-
gar/bcg-gartb-eng.asp
► Center of Regulatory Expertise (TBS)► Regulatory Bootcamp Module 5 – CBA